Reduced glutathione protects against cisplatin-induced neurotoxicity in rats

FPT Hamers, JH Brakkee, E Cavalletti, M Tedeschi… - Cancer research, 1993 - AACR
Reduced glutathione (GSH) is reported to diminish cisplatin-induced neurotoxicity, and it
was for this reason that we studied GSH in an animal model of cisplatin neuropathy. The …

A Preliminary Clinical Study of Cyclophosphamide with Reduced Glutathione Asc Uroprotector

…, M Benasso, M Venturini, M Tedeschi… - Tumori …, 1989 - journals.sagepub.com
Questo studio è basato sull'osservazione che il glutattione ridotto è efficace quale agente
protettivo nei confronti della urotossicità indotta da ciclofosfamide in modelli sperimentali, in …

Artificial intelligence in hypertension management: an ace up your sleeve

…, C Izzo, C Mancusi, A Rispoli, M Tedeschi… - Journal of …, 2023 - mdpi.com
Arterial hypertension (AH) is a progressive issue that grows in importance with the increased
average age of the world population. The potential role of artificial intelligence (AI) in its …

Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: Report of an international multicenter cohort study with propensity score matching

…, L Schwarz, M Scotte, FR Souche, B Suc, M Tedeschi… - Surgery, 2022 - Elsevier
Background Intrahepatic cholangiocarcinoma is a rare disease with a poor prognosis. In
patients where surgical resection is possible, outcome is influenced by perioperative morbidity …

[PDF][PDF] IgG serology in health care and administrative staff populations from 7 hospital representative of different exposures to SARS-CoV-2 in Lombardy, Italy

MT Sandri, E Azzolini, V Torri, S Carloni, M Tedeschi… - MedRxiv, 2020 - researchgate.net
Lombardy is one of the regions in Italy most affected by COVID-19. We assessed the diffusion
of the virus via testing plasma anti-SARS-CoV-2 IgG antibodies in 3985 employees of 7 …

Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?

M Bellino, G Galasso, A Silverio, M Tedeschi… - Journal of Clinical …, 2023 - mdpi.com
Current research on cardiovascular prevention predominantly focuses on risk-stratification
and management of patients with coronary artery disease (CAD) to optimize their prognosis. …

SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy

…, V Torri, S Carloni, C Pozzi, M Salvatici, M Tedeschi… - Scientific Reports, 2021 - nature.com
Lombardy is the Italian region most affected by COVID-19. We tested the presence of plasma
anti-SARS-CoV-2 IgG antibodies in 3985 employees across 7 healthcare facilities in areas …

Hepatocellular carcinoma with bile duct tumor thrombus: A case report and literature review of 890 patients affected by uncommon primary liver tumor presentation

…, R Inchingolo, R Calbi, V Ferraro, M Tedeschi… - Journal of Clinical …, 2023 - mdpi.com
Bile duct tumor thrombus (BDTT) is an uncommon finding in hepatocellular carcinoma (HCC),
potentially mimicking cholangiocarcinoma (CCA). Recent studies have suggested that …

Performance of comprehensive complication index and Clavien-Dindo complication scoring system in liver surgery for hepatocellular carcinoma

…, V Sega, P Calcagno, L Pennacchi, M Tedeschi… - Cancers, 2020 - mdpi.com
Simple Summary The comprehensive complication index (CCI) and the Clavien-Dindo
Complication (CDC) scoring system are two metrics designed to quantify the burden of …

SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry

…, CS Dini, M Briani, M Tedeschi… - Catheterization and …, 2023 - Wiley Online Library
Background Cardiogenic shock (CS) includes several phenotypes with heterogenous
hemodynamic features. Timely prognostication is warranted to identify patients requiring treatment …